CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Methylprednisolone and Lidocaine +2 moredrug
Likely dose
Methylprednisolone and Lidocaine 80 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00682357
NCT00682357N/ACompleted
CompareCT.gov

Effect of Intraarticular Steroids on Bone Turnover in Osteoarthritis

University of Kansas Medical Center·interventional·Posted May 22, 2008·Updated Aug 13, 2024

In Brief

A clinical study evaluating Methylprednisolone and Lidocaine and Placebo and Lidocaine for Osteoarthritis. Completed, enrolled 25 participants across 1 site.

Detailed Summary

Oral and nasal steroids may enhance osteoporosis by suppressing bone formation. Intra-articular steroids may also suppress bone formation, however, the duration or relationship to a steroid dose has not been established. It is hypothesized that intra-articular steroids suppress bone formation transiently, returning to pretreatment levels within four weeks in subjects with osteoarthritis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 22, 2008
Enrollment StartMay 1, 2008
Primary CompletionNov 1, 2009
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 18.1 years ago

Interventions

Methylprednisolone and Lidocainedrug

Methylprednisolone 80 mg, intra-articular and lidocaine 20 mg

Methylprednisolone and Lidocainedrug

Methylprednisolone 16 mg intra-articular and lidocaine 20 mg

Placebo and Lidocainedrug

Placebo and lidocaine 20 mg